GAAP

Constellation Brands to Report Full Fiscal Year and Fourth Quarter 2024 Financial Results; Host Conference Call April 11, 2024

Retrieved on: 
Thursday, March 7, 2024

VICTOR, N.Y., March 07, 2024 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today it will report financial results for its full fiscal year and fourth quarter ended February 29, 2024, on Thursday, April 11, 2024, before the open of the U.S. markets.

Key Points: 
  • VICTOR, N.Y., March 07, 2024 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today it will report financial results for its full fiscal year and fourth quarter ended February 29, 2024, on Thursday, April 11, 2024, before the open of the U.S. markets.
  • A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer, Bill Newlands, and Executive Vice President and Chief Financial Officer, Garth Hankinson, at 10:30 a.m. EDT, April 11, 2024.
  • The conference call can be accessed by dialing +1-877-407-9121 and entering conference identification number 13744624, beginning at 10:20 a.m. EDT.
  • For anyone unable to participate in the conference call, a replay will be available on the company’s investor relations website.

Bilibili Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results

Retrieved on: 
Thursday, March 7, 2024

Fourth Quarter and Fiscal Year 2023 Highlights:

Key Points: 
  • Fourth Quarter and Fiscal Year 2023 Highlights:
    Total net revenues were RMB6.3 billion (US$894.3 million) in the fourth quarter of 2023 and RMB22.5 billion (US$3.2 billion) in 2023, each increased by 3% compared with the same prior year period.
  • Advertising revenues were RMB1.9 billion (US$271.7 million) in the fourth quarter of 2023, and RMB6.4 billion (US$903.1 million) in 2023, representing increases of 28% and 27% year over year, respectively.
  • Gross profit margin reached 26.1% in the fourth quarter of 2023, improving from 20.3% in the same period last year.
  • Net loss was RMB1.3 billion (US$182.6 million) in the fourth quarter of 2023 and RMB4.8 billion (US$677.7 million) in 2023, narrowing by 13% and 36% year over year, respectively.

Global Water Resources Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Thursday, March 7, 2024

PHOENIX, March 06, 2024 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, reported results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • PHOENIX, March 06, 2024 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, reported results for the fourth quarter and full year ended December 31, 2023.
  • Water consumption increased 19.4% to 0.90 billion gallons in the fourth quarter of 2023.
  • Recycled water volume increased 12.6% to 818 million gallons in the fourth quarter of 2023.
  • Global Water Resources will hold a conference call tomorrow to discuss its fourth quarter and full year 2023 results, including a question-and-answer period.

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Retrieved on: 
Thursday, March 7, 2024

Net loss: Net loss for the fourth quarter 2023 was $79.6 million, compared to $55.0 million for fourth quarter 2022.

Key Points: 
  • Net loss: Net loss for the fourth quarter 2023 was $79.6 million, compared to $55.0 million for fourth quarter 2022.
  • Fourth quarter 2023 net loss included a non-cash charge related to stock-based compensation of $24.6 million compared to $6.7 million for fourth quarter 2022.
  • Phathom will host a conference call and webcast to discuss its fourth quarter and full year 2023 financial results and business highlights today, March 7, 2024, at 8:30 a.m.
  • Phathom believes the presentation of these non-GAAP financial measures provides useful information to management and investors regarding Phathom's results of operations.

AFC Gamma, Inc. Announces Financial Results for Fourth Quarter and Full Year 2023

Retrieved on: 
Thursday, March 7, 2024

WEST PALM BEACH, Fla., March 07, 2024 (GLOBE NEWSWIRE) -- AFC Gamma, Inc. (NASDAQ:AFCG) (“AFC Gamma” or the “Company”) today announced its results for the fourth quarter and year ended December 31, 2023.

Key Points: 
  • WEST PALM BEACH, Fla., March 07, 2024 (GLOBE NEWSWIRE) -- AFC Gamma, Inc. (NASDAQ:AFCG) (“AFC Gamma” or the “Company”) today announced its results for the fourth quarter and year ended December 31, 2023.
  • “AFC Gamma has made significant progress on portfolio management initiatives in the fourth quarter and into 2024 in spite of a challenging cannabis backdrop,” said Daniel Neville, the Company’s Chief Executive Officer.
  • For the fourth quarter of 2023, AFC Gamma distributed $9.8 million in dividends, or $0.48 per common share, compared to Distributable Earnings of $0.49 per basic weighted average common share for such period.
  • AFC Gamma issued a presentation of its fourth quarter and full year 2023 results, titled “Fourth Quarter and Annual 2023 Earnings Presentation,” which can be viewed at www.afcgamma.com under the Investor Relations section.

Harvard Bioscience Announces Fourth Quarter 2023 Financial Results

Retrieved on: 
Thursday, March 7, 2024

For the fourth quarter of fiscal 2023, the Company reported revenues of $28.2 million compared to $28.4 million in the fourth quarter of fiscal 2022 and included a net reduction of $0.9 million from discontinued products from the fourth quarter of 2022.

Key Points: 
  • For the fourth quarter of fiscal 2023, the Company reported revenues of $28.2 million compared to $28.4 million in the fourth quarter of fiscal 2022 and included a net reduction of $0.9 million from discontinued products from the fourth quarter of 2022.
  • Net loss for the fourth quarter of 2023 was $(1.8) million and included an unfavorable impact of a $(0.3) million unrealized loss on marketable securities.
  • Adjusted EBITDA for the fourth quarter of 2023 was $3.6 million, compared to $3.7 million in the fourth quarter of the prior year.
  • Cash provided by operations for the fourth quarter of 2023 was $4.3 million compared to $2.7 million in the same period last year.

Vital Farms Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Retrieved on: 
Thursday, March 7, 2024

AUSTIN, Texas, March 07, 2024 (GLOBE NEWSWIRE) -- Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, today reported financial results for its fourth quarter (14 weeks) and fiscal year (53 weeks) ended December 31, 2023.

Key Points: 
  • Financial highlights for the fourth quarter ended December 31, 2023 (14 weeks) compared to the fourth quarter ended December 25, 2022 (13 weeks):
    Net Revenue increased 23.4% to $135.8 million, compared to $110.1 million.
  • For the 14 Weeks Ended December 31, 2023
    Net revenue increased 23.4% to $135.8 million in the fourth quarter of 2023, compared to $110.1 million in the fourth quarter of 2022.
  • Income from operations in the fourth quarter of 2023 was $9.1 million, compared to income from operations of $3.4 million in the fourth quarter of 2022.
  • Thilo Wrede, Vital Farms’ Chief Financial Officer, commented: “We are very pleased with the financial performance we delivered in the fourth quarter and throughout 2023, highlighted by our record net revenue and improved profitability.

Burlington Stores, Inc. Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Thursday, March 7, 2024

Michael O’Sullivan, CEO, stated, “Our performance in the fourth quarter exceeded our guidance.

Key Points: 
  • Michael O’Sullivan, CEO, stated, “Our performance in the fourth quarter exceeded our guidance.
  • Diluted weighted average shares outstanding amounted to 64.4 million during the quarter compared with 65.4 million during the fourth quarter of Fiscal 2022.
  • During the fourth quarter the Company repurchased 605,311 shares of its common stock under its share repurchase program for $103 million.
  • ET to discuss the Company’s fourth quarter and fiscal 2023 results.

ABM Reports First Quarter Fiscal 2024 Results and Raises Outlook for Fiscal Year 2024 Adjusted EPS

Retrieved on: 
Thursday, March 7, 2024

“ABM is off to an excellent start in 2024, generating revenue growth of 3.9%,” said Scott Salmirs, President & Chief Executive Officer.

Key Points: 
  • “ABM is off to an excellent start in 2024, generating revenue growth of 3.9%,” said Scott Salmirs, President & Chief Executive Officer.
  • For the first quarter of fiscal 2024, the Company reported revenue of $2.1 billion, up 3.9% over the prior year period, all of which was organic growth.
  • Adjusted EBITDA for the first quarter decreased 5% to $116.7 million and adjusted EBITDA margin was 5.9% versus 6.4% last year.
  • Based on solid first quarter results and the recognition of certain discrete tax benefits, ABM is raising its outlook for fiscal year 2024 (“FY24”) adjusted EPS.

DBV Technologies Reports Full Year 2023 Financial Results and Business Update

Retrieved on: 
Thursday, March 7, 2024

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today reported financial results for the full year 2023.

Key Points: 
  • DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today reported financial results for the full year 2023.
  • Published EPITOPE results in the New England Journal of Medicine with an accompanying editorial, entitled, Good News for Toddlers with Peanut Allergy.
  • ET to discuss full year 2023 financial results and provide a business update.
  • The conference call may be accessed by dialing:
    A webcast of the call will also be available under "Events" in the Investors section of the DBV Technologies website: https://dbv-technologies.com/investor-overview/events .